These 2 Healthcare Stocks Just Declared Dividend Raises
While the pre-holiday season isn't usually a busy time for dividend raises, investors can usually expect a few companies to end the year on a high note by declaring one.
Sure enough, in the fading weeks of 2025, we've seen a smattering of payout hikes. Two of the more notable dividend raises were declared by healthcare sector mainstays Bristol Myers Squibb (NYSE: BMY) and (NYSE: ZTS). Let's take a brief, flyover look at both.
Storied pharmaceutical company Bristol Myers Squibb has a long history of paying dividends; it has done so for 94 consecutive years. It's also declared dividend raises for 17 years in a row, most lately with its mid-December declaration of an upcoming $0.63-per-share quarterly payout. That's a 1.6% increase.
Source Fool.com
Zoetis Inc. A Aktie
Deutliche Buy-Präferenz bei Zoetis Inc. A ohne Sell-Einschätzungen.
Das Kursziel von 179 € für Zoetis Inc. A bedeutet eine deutliche Steigerung von über 50% gegenüber dem aktuellen Kurs von 105.3 €.
